The cause of SIDS is unknown, but scientists are exploring a brain receptor that could be involved in a subset of infant SIDS deaths.
Author: Nada Hassanein, USA TODAY
Shattered houses, crushed cars: Photos show destruction from Texas tornado that left at least 1 dead
An overnight Rio Grande Valley tornado left one dead, several injured and damaged dozens of homes.
This group of young women is seeing a staggering rise in uterine cancer. Experts don’t know why.
Uterine cancer is long known to affect Black women disparately. Now, data shows this alarming trend is affecting young, Hispanic women.
Does COVID-19 during pregnancy lead to neurodevelopmental problems in babies?
Authors of recent studies said longer follow-up is needed to fully understand how and if COVID-19 in pregnant people affects infant neurodevelopment.
A third of Americans don’t have a primary care provider, report finds
Over 100 million Americans don’t have a primary care doctor. Community health centers can fill the gap, advocates say.
A ‘quiet’ liver disease is on the rise in kids and Hispanic people: What you need to know
Nonalcoholic fatty liver disease affects as many as 1 in 3 people, but it often comes with no symptoms. Experts discuss who it’s affecting most.
Preventable injuries are killing America’s children. But some are more at risk than others.
Experts say pediatric injuries are a public health crisis, but more data is needed to understand where kids are most in danger and why.
‘Time to sound the alarm’: Surge in babies born with syphilis draws attention to lack of care
A surge in babies born with congenital syphilis in Mississippi is calling attention to rising cases throughout the nation, especially the South.
Diabetes in kids and young people is projected to dramatically surge. Can it be prevented?
The number of children and young people under 20 with Type 2 diabetes could jump by nearly 700% by 2060, a CDC study finds.
A new HIV treatment shot is given only twice a year. It could be a ‘game changer.’
Senlenca, a new injection regimen for HIV, is for patients who have suffered drug resistance. But experts worry about the hefty cost.